Osteoarthritis Trial, Recruiting NCT07006883 Sponsor: University of Nove de Julho Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT07006883
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been clinically diagnosed with knee osteoarthritis, meaning they have had knee pain for more than 3 months
  • People whose morning joint stiffness lasts less than 30 minutes
  • People whose knees make a cracking or grinding sound when moving (crepitus)
  • People who have tenderness in the bone around the knee, no noticeable warmth in the knee, and/or whose knee osteoarthritis has been confirmed by an X-ray showing a moderate level of joint changes (graded 1 to 3 on the Kellgren and Lawrence scale)

Who may not be able to join:

  • People who have osteoarthritis affecting both hips or both knees at the same time
  • People with severe osteoporosis (significant loss of bone density)
  • People who have fibromyalgia (a condition causing widespread pain)
  • People with a history of tumors or cancer
  • People with active inflammatory joint conditions such as rheumatoid arthritis or gout, or who are currently undergoing a joint replacement surgery in the lower body
  • People with neurological conditions such as Parkinson's disease, stroke, multiple sclerosis, muscular dystrophies, Alzheimer's disease, or other nerve and muscle disorders
  • People with infected wounds or bone infections in or around the knee
  • People with deep vein thrombosis (blood clots in the leg), thrombophlebitis (inflamed veins), or changes in sensation in the lower limbs
  • People with cognitive (thinking or memory) or heart and lung conditions that may prevent them from safely completing exercise activities
  • People who use a walking aid, or who have had a recent knee injury
  • People who have received — or are currently receiving — any of the following in the six months before the trial begins: physiotherapy, steroid injections into the joint, anti-inflammatory medications, opioid pain medications, or cartilage-protective treatments

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Nove de Julho
Registry
ClinicalTrials.gov
Start date
1 August 2025
Est. completion
30 January 2029

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

Functional disability

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov